Filing Flows

Filing Flows › Health Care › Ardent Health (ARDT)

Ardent Health (ARDT) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Ardent Health (ARDT) Q3 2026 earnings results →

Q3 2026 Revenue up 3% year over year to $1.6B · 3¢ of every $1 of revenue kept as net profit · operating margin 5.0%

Ardent Health made $1.6B in Q3 2026 (+3% Y/Y). Operating margin 5.0%, net earnings $44.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$1.6B
Year over year+3%
Operating margin5.0%
Net earnings$44.5M
Operating cash flow$122M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

Ardent Health Q3 2026 revenue breakdown: Sankey diagram of revenue, costs, profit and cash flow
Ardent Health Q3 2026 revenue breakdown — free to use with credit and a link (terms). Share on X
Embed this chart on your site

Free to use with the credit line. Click a box to select the code.

What changed this quarter

Revenue was $1.6B in Q3 2026, up 3% year over year and roughly flat from the previous quarter.

Operating profit was $0.08B, a 5.0% margin (up 5.1 points year over year). Total costs fell 2% while revenue rose 3%. The fastest-growing cost line was General & admin (+16%). Net earnings were $0.04B. The effective tax rate was 21.8%.

Operating cash flow was $0.12B (down 21% year over year), 192% of net income including minority interests. Non-cash charges added back $0.04B of depreciation and amortization. Working capital and other items added $0.02B.

Quarterly history

Ardent Health revenue by quarterArdent Health revenue by quarter$1.5BQ1 2025$1.6BQ2 2025$1.6BQ3 2025$1.6BQ4 2025$1.6BQ1 2026$1.6BQ2 2026$1.6BQ3 2026
Ardent Health net earnings by quarterArdent Health net earnings by quarter$41.4MQ1 2025$73.0MQ2 2025$1.2MQ3 2025$45.0MQ4 2025$39.9MQ1 2026$16.9MQ2 2026$44.5MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$1.6B+3%5.0%$44.5M$122M
Q2 202610-QAug 10, 2026$1.6B-1%2.7%$16.9M$197M
Q1 202610-QMay 6, 2026$1.6B+7%4.7%$39.9M−$60.2M
Q4 202510-KMar 16, 2026$1.6B-0.1%5.8%$45.0M$223M
Q3 202510-QNov 14, 2025$1.6B+9%-0.1%$1.2M$154M
Q2 202510-QAug 6, 2025$1.6B+12%7.4%$73.0M$117M
Q1 202510-QMay 7, 2025$1.5B+4%5.0%$41.4M−$24.8M

Charts

Ardent Health: revenue growth, year over year and quarter over quarterArdent Health: revenue growth, year over year and quarter over quarterY/YQ/Q+4%Q1 2025+12%+10%Q2 2025+9%-4%Q3 20250%+2%Q4 2025+7%0%Q1 2026-1%+1%Q2 2026+3%+0%Q3 2026
Latest (Q3 2026): Y/Y +3%, Q/Q +0%.
Ardent Health: where the cash came from (+) and went (−), TTM to Q3 2026Ardent Health: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$482MOther investing−$193MCash drawn (+) / kept (−)−$157MPartners−$94.2MOther financing−$23.1MNet borrowing (+) / repaid (−)−$14.3M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Ardent Health: profit against cash, quarter by quarterArdent Health: profit against cash, quarter by quarterNet incomeOperating cash flow$141M$120MQ4 2024$59.0M−$24.8MQ1 2025$95.7M$117MQ2 2025$1.2M$154MQ3 2025$74.3M$223MQ4 2025$58.5M−$60.2MQ1 2026$34.7M$197MQ2 2026$63.4M$122MQ3 2026
Latest (Q3 2026): Net income $63.4M, Operating cash flow $122M.
Ardent Health: diluted shares by fiscal yearArdent Health: diluted shares by fiscal year126MFY2022126MFY2023133MFY2024141MFY2025
+12.2% since FY2022: more shares outstanding (issuance, stock pay).
Ardent Health: long-term debt falling due (FY2025)Ardent Health: long-term debt falling due (FY2025)$23.4M2026$15.1M2027$12.5M2028$312M2029$8.6M2030$745MLater
Cash $710M, short-term investments —, long-term debt $1.1B at 2025-12-31.
Ardent Health in its industry: growth against margin (6 companies, SIC 8062)Ardent Health in its industry: growth against margin (6 companies, SIC 8062)revenue growth, year over year →↑ operating marginmedian +4%median 12%HCATHCUHSCYHSGRYARDT (+3%, 5%)
Services-General Medical & Surgical Hospitals, NEC; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Ardent Health

Ardent Health, Inc. was initially formed in Delaware in 2015 as Ardent Health Partners, LLC. On July 17, 2024, Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. On June 3, 2025, Ardent Health Partners, Inc. changed its name to Ardent Health, Inc. Ardent Health, Inc. is a holding company that has affiliates that operate acute care hospitals and other healthcare facilities and employ physicians. The terms "Ardent," the "Company," "we," "our" and "us," as used in this Annual Report on Form 10-K ("Annual Report"), refer to Ardent Health, Inc. and its affiliates and, on or prior to July 16, 2024, Ardent Health Partners, LLC and its affiliates, unless stated otherwise or indicated by context.

In its own words, from its 10-K, filed Mar 16, 2026.

Ardent Health against its Services-General Medical & Surgical Hospitals, NEC peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +3% against the peers' median +4%. Operating margin: 5.0% against the peers' median 11.9%.

CompanyQuarterRevenueY/YOp. margin
ARDT Ardent HealthQ3 2026$1.6B+3%5.0%
HCA HCA HealthcareQ3 2026$19.8B+4%11.9%
THC Tenet HealthcareQ3 2026$5.6B+6%31.1%
UHS Universal Health ServicesQ3 2026$4.7B+5%9.6%
CYH Community Health SystemsQ3 2026$2.8B-11%5.3%
SGRY Surgery PartnersQ2 2026$849M+3%12.0%

Source: Ardent Health 10-Q on SEC EDGAR · CIK 1756655 · Services-General Medical & Surgical Hospitals, NEC

Guidance and outlook

Ardent Health: what its forward-looking statements are about (10-Q filed 2026-11-05)Ardent Health: what its forward-looking statements are about (10-Q filed 2026-11-05)Other9Financing2Demand2Deals1Legal & regulation1Tax1Capital spending1
17 statements; tone -0.18 (−1 all cautious, +1 all confident); 3 hedged.
Ardent Health: outlook statements against the filing beforeArdent Health: outlook statements against the filing beforeConfident1Cautious4

13F: who owns ARDT and who is buying

Largest holders of ARDT (13F)Largest holders of ARDT (13F)Chai Trust Co LLC$760MVentas$91.9MBlackRock$21.4MAmeriprise Financial$20.8MGoldentree Asset Management LP$15.5MAQR Capital Management LLC$14.2MVanguard Group$13.3MCastleKnight Management LP$10.6MVanguard Capital Management LLC$9.5MBridgeway Capital Management, LLC$8.3M
Funds' net buying of ARDT by quarter (13F)Funds' net buying of ARDT by quarter (13F)$1.5B2024-09−$22.6M2024-12−$34.0M2025-03$5.7M2025-06$31.4M2025-09−$6.5M2025-12$3.1M2026-03$15.7M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on ARDT

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare ARDT with

中文版:Ardent Health(ARDT)财报

Español · Français